Abstract
Increased flux of glucose through the hexosamine biosynthetic pathway (HSP) is believed to mediate hyperglycemia-induced insulin resistance in diabetes. The end product of the HSP, UDPβ- N -acetylglucosamine (GlcNAc), is a donor sugar nucleotide for complex glycosylation in the secretory pathway and for O-linked GlcNAc (O-GlcNAc) addition to nucleocytoplasmic proteins. Cycling of the O-GlcNAc posttranslational modification was blocked by pharmacological inhibition of O-GlcNAcase, the enzyme that catalyzes O-GlcNAc removal from proteins, with O -(2-acetamido-2-deoxy- d -glucopyranosylidene)amino- N -phenylcarbamate (PUGNAc). PUGNAc treatment increased levels of O-GlcNAc and caused insulin resistance in 3T3-L1 adipocytes. Insulin resistance induced through the HSP by glucosamine and chronic insulin treatment correlated with increased O-GlcNAc levels on nucleocytoplasmic proteins. Whereas insulin receptor autophosphorylation and insulin receptor substrate 2 tyrosine phosphorylation were not affected by PUGNAc inhibition of O-GlcNAcase, downstream phosphorylation of Akt at Thr-308 and glycogen synthase kinase 3β at Ser-9 was inhibited. PUGNAc-induced insulin resistance was associated with increased O-GlcNAc modification of several proteins including insulin receptor substrate 1 and β-catenin, two important effectors of insulin signaling. These results suggest that elevation of O-GlcNAc levels attenuate insulin signaling and contribute to the mechanism by which increased flux through the HSP leads to insulin resistance in adipocytes.
References
62
Referenced
401
- H Yki-Jarvinen, V Koivisto Ann Clin Res 16, 74–83 (1984). / Ann Clin Res by Yki-Jarvinen H (1984)
10.2337/diacare.15.3.418
- Y T Kruszynska, J M Olefsky J Invest Med 44, 413–428 (1996). / J Invest Med by Kruszynska Y T (1996)
10.1172/JCI112981
- S R Hager, A L Jochen, R K Kalkhoff Am J Physiol 260, E353–E362 (1991). / Am J Physiol by Hager S R (1991)
10.1038/414813a
10.2337/diacare.13.6.610
10.1016/S0021-9258(19)67706-9
10.1172/JCI118876
10.2337/diab.45.8.1003
10.2337/diab.42.9.1333
10.1172/JCI118013
10.1007/BF00400719
10.1172/JCI118349
10.1172/JCI119390
10.1146/annurev.biochem.66.1.315
10.1096/fj.01-0094rev
10.1074/jbc.272.14.9308
10.1074/jbc.272.14.9316
10.1074/jbc.274.45.32015
10.1074/jbc.275.15.10983
10.1016/S0026-0495(98)90058-0
10.1007/978-1-4615-1885-3_10
10.1006/bbrc.1997.6110
10.1016/S0300-9084(01)01295-0
10.1126/science.1058714
10.1074/jbc.270.32.18961
10.1016/S0021-9258(18)82216-5
10.1074/jbc.271.46.28741
10.1021/bi0027480
10.1074/jbc.R000010200
10.1016/S0304-4165(99)00105-1
10.1210/endo-128-5-2415
10.1016/S0021-9258(17)32170-1
10.1074/jbc.M010420200
10.1074/jbc.M109656200
10.1074/jbc.273.6.3611
10.1074/jbc.272.12.7759
10.1073/pnas.87.1.251
10.1016/S0021-9258(19)85559-X
10.1006/abio.2001.5132
10.1016/S0021-9258(18)89409-1
- Y Kido, J Nakae, D Accili J Clin Endocrinol Metab 86, 972–979 (2001). / J Clin Endocrinol Metab by Kido Y (2001)
10.1074/jbc.271.49.31372
10.1128/MCB.19.6.4008
10.1128/MCB.18.12.6971
10.1016/S0960-9822(06)00122-9
10.1042/bj2940625
10.1038/378785a0
10.1074/jbc.273.21.13150
10.1126/science.254.5029.274
- M F White Recent Prog Horm Res 53, 119–138 (1998). / Recent Prog Horm Res by White M F (1998)
10.1046/j.1365-2443.1998.00198.x
10.1074/jbc.273.18.10823
10.2337/diabetes.49.6.981
10.1073/pnas.97.22.12222
10.2337/diabetes.48.8.1562
10.1074/jbc.M108594200
- E Heart, W S Choi, C K Sung Am J Physiol 278, E103–E112 (2000). / Am J Physiol by Heart E (2000)
10.1038/sj.onc.1204064
10.1093/emboj/20.21.5999
10.1128/MCB.21.5.1633-1646.2001
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:45 a.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 5:10 p.m.) |
Indexed | 1 week ago (Aug. 20, 2025, 8:33 a.m.) |
Issued | 23 years, 4 months ago (April 16, 2002) |
Published | 23 years, 4 months ago (April 16, 2002) |
Published Online | 23 years, 4 months ago (April 16, 2002) |
Published Print | 23 years, 4 months ago (April 16, 2002) |
@article{Vosseller_2002, title={Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes}, volume={99}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.072072399}, DOI={10.1073/pnas.072072399}, number={8}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Vosseller, Keith and Wells, Lance and Lane, M. Daniel and Hart, Gerald W.}, year={2002}, month=apr, pages={5313–5318} }